Hypothalmic and Pituitary Hormones

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/22

encourage image

There's no tags or description

Looks like no tags are added yet.

23 Terms

1
New cards

Cosyntropin MOA

synthetic formulation of ACTH

2
New cards

Cosyntropin primary indication

1) used to distinguish CAH from ovarian hyperandrogenism

2) used to diagnose adrenal insufficiency

3
New cards

Cosyntropin notable aspect

not used therapeutically, only for diagnostic purposes

4
New cards

Somatostatin MOA

inhibits secretion of growth hormones

5
New cards

Somatostatin primary indication

excess growth hormone

6
New cards

Somatostatin notable aspect

very short half-life of a few minutes

7
New cards

Octreotide MOA

inhibits secretion of growth hormones

inhibits insulin secretion

8
New cards

Octreotide primary indication

treatment of acromegaly

treatment of carcinoid tumors

9
New cards

Octreotide notable aspect

longer half-life than somatostatin

10
New cards

Leuprolide MOA

synthetic GnRH agonist

11
New cards

Leuprolide primary indication

  • continuous administration: initially increases LH/FSH before suppressing them through receptor downregulation

  • pulsatile administration - used to treat GnRH deficiency and mimic natural pulsatile secretion of GnRH


12
New cards

Leuprolide notable aspect

continuous administration can be used in the treatment of central precocious puberty

13
New cards

Cabergoline MOA

Dopamine agonist

  • since dopamine leads to suppression of prolactin, it can decrease prolactin levels


14
New cards

Cabergoline primary indication

Hyperprolactinemia (often from a prolactin-secreting pituitary adenoma)

15
New cards

Desmopressin MOA

  • long acting synthetic analog of vasopressin

  • acts on V2 receptors in kidneys to increase water reabsorption by causing insertion of aquaporin channels


16
New cards

Desmopressin primary indication

  • treatment of nocturnal enuresis

  • treatment of diabetes insipidus

  • can be used to control bleeding


17
New cards

Desmopressin notable aspect

use with caution in patients with coronary artery disease

18
New cards

Conivaptan MOA

dual vasopressin antagonist at V1 and V2 receptors

19
New cards

Conivaptan primary indication

treatment of euvolemic and hypervolemic hyponatremia

20
New cards

Tolvaptan MOA

selective Vasopressin antagonist at the V2 receptors

21
New cards

Tolvaptan primary indication

  • treatment of euvolemic and hypervolemic hyponatremia

  • treatment of SIADH (inappropriate anti-diuretic hormone)


22
New cards

Oxytocin MOA

synthetic oxytocin

23
New cards

Oxytocin primary indication

  • induces and enhances uterine contractions in labor

  • prevention and treatment of postpartum hemorrhage